WHO - Draft Guidelines on GCP

29th July 2026

The WHO has recently published a draft guideline, including two annexes, on Good Clinical Practice (GCP) for clinical trials involving medicinal products. Comments on these documents may be submitted until 6 September 2026 (which can be done on the PleaseReviewTM online platform).

Access the documens here:

• Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products - Main Principles (QAS/26.995)
• Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products - Annex 1 (QAS/26.995)
• Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products - Annex 2 (QAS/26.995)

Back to Recent News